These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17880843)

  • 1. Repeated botulinum toxin injection for idiopathic overactive bladder: will chemodenervation become a long-term solution?
    Unwala DJ; Barboglio P; Gousse AE
    Curr Urol Rep; 2007 Sep; 8(5):419-24. PubMed ID: 17880843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of intravesical injections of botulinum toxin type A in patients with refractory idiopathic overactive bladder.
    Juszczak K; Adamczyk P; Maciukiewicz P; Drewa T
    Pharmacol Rep; 2018 Dec; 70(6):1133-1138. PubMed ID: 30317128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates.
    Dowson C; Watkins J; Khan MS; Dasgupta P; Sahai A
    Eur Urol; 2012 Apr; 61(4):834-9. PubMed ID: 22204745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.
    Marcelissen TA; Rahnama'i MS; Snijkers A; Schurch B; De Vries P
    World J Urol; 2017 Feb; 35(2):307-311. PubMed ID: 27272312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation.
    Sherif H; Khalil M; Omar R
    Can J Urol; 2017 Jun; 24(3):8838-8846. PubMed ID: 28646940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder.
    Kantartzis K; Shepherd J
    Curr Opin Obstet Gynecol; 2012 Oct; 24(5):331-6. PubMed ID: 22922403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin for overactive bladder].
    Ziegelmüller BK; Sommer A; Bauer RM
    Urologe A; 2020 Aug; 59(8):963-972. PubMed ID: 32691107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum a toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1/2 study.
    Petrou SP; Parker AS; Crook JE; Rogers A; Metz-Kudashick D; Thiel DD
    Mayo Clin Proc; 2009 Aug; 84(8):702-6. PubMed ID: 19648387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin-A injections for idiopathic overactive bladder: a systematic review and meta-analysis.
    Cui Y; Wang L; Liu L; Zeng F; Niu J; Qi L; Chen H
    Urol Int; 2013; 91(4):429-38. PubMed ID: 23970316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged urinary retention after intravesical botulinum injection for treatment of idiopathic detrusor overactivity.
    King AB; Rapp DE
    Can J Urol; 2011 Apr; 18(2):5657-9. PubMed ID: 21504656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie J; Wilson DI; Herbison GP; Wilson D
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity.
    Veeratterapillay R; Harding C; Teo L; Vasdev N; Abroaf A; Dorkin TJ; Pickard RS; Hasan T; Thorpe AC
    Int J Urol; 2014 Feb; 21(2):175-8. PubMed ID: 23819724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report.
    Al Edwan GM; Mansi HH; Atta ONM; Shaath MM; Al Adwan R; Mahafza W; Afram KM; Ababneh O; Al Adwan D; Muheilan MM
    J Pediatr Surg; 2019 Mar; 54(3):595-599. PubMed ID: 29887168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics.
    Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1242-8. PubMed ID: 21560152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: lack of anticholinergic efficacy versus intolerability.
    Makovey I; Davis T; Guralnick ML; O'Connor RC
    Neurourol Urodyn; 2011 Nov; 30(8):1538-40. PubMed ID: 21826718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome.
    Kuo HC; Liao CH; Chung SD
    Eur Urol; 2010 Dec; 58(6):919-26. PubMed ID: 20864251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onabotulinum toxin A Injections in Men With Refractory Idiopathic Detrusor Overactivity.
    Faure Walker NA; Syed O; Malde S; Taylor C; Sahai A
    Urology; 2019 Jan; 123():242-246. PubMed ID: 30266377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of botulinum toxin type A in the single and repeated treatment of overactive bladder. A prospective analysis].
    Frohme C; Varga Z; Olbert P; Schrader AJ; Hofmann R; Hegele A
    Urologe A; 2010 May; 49(5):639-44. PubMed ID: 20182692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An indirect comparison meta-analysis of noninvasive intravesical instillation and intravesical injection of botulinum toxin-A in bladder disorders.
    Yunfeng G; Fei L; Junbo L; Dingyuan Y; Chaoyou H
    Int Urol Nephrol; 2022 Mar; 54(3):479-491. PubMed ID: 35044552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.